Summit Trail Advisors LLC Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

Summit Trail Advisors LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,964 shares of the company’s stock after acquiring an additional 352 shares during the period. Summit Trail Advisors LLC’s holdings in HCA Healthcare were worth $1,190,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in HCA. FMR LLC grew its stake in HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Meritage Group LP acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $150,548,000. Canoe Financial LP grew its stake in HCA Healthcare by 226,952.9% in the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after acquiring an additional 231,492 shares during the last quarter. Holocene Advisors LP boosted its stake in shares of HCA Healthcare by 210.6% during the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after purchasing an additional 208,015 shares during the last quarter. Finally, Nordea Investment Management AB boosted its stake in shares of HCA Healthcare by 29.7% during the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after purchasing an additional 193,075 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 1.7 %

HCA stock opened at $323.71 on Wednesday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a market capitalization of $81.99 billion, a P/E ratio of 14.73, a PEG ratio of 1.11 and a beta of 1.64. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a 50 day simple moving average of $313.56 and a 200-day simple moving average of $353.26.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company earned $5.90 earnings per share. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.89%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 12.02%.

Wall Street Analyst Weigh In

Several research firms have issued reports on HCA. KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Morgan Stanley decreased their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Finally, Bank of America decreased their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.